Meclizine 25
Product Images NDC 57963-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Meclizine 25 (NDC 57963-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The Generic Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
This is a medication called Meclizine, which is an antiemetic used to prevent and treat symptoms of motion sickness such as nausea, vomiting, and dizziness. Each tablet contains 25mg of Meclizine HCI. It should not be used for children under 12 years without a doctor's direction and should be avoided if you have certain medical conditions such as glaucoma, difficulty in urination due to prostate enlargement, or breathing problems like emphysema or chronic bronchitis. If pregnant or breastfeeding, consult a healthcare professional before use. The medication should be kept out of reach of children, and in case of accidental overdose, medical help or Poison Control Center should be contacted immediately. The medication is manufactured and distributed by The Generic Pharmaceutical Company and contains inactive ingredients such as Magnesium Stearate, Microcrystalline Cellulose, and Sodium Starch Glycolate. The medication should be stored at 59°-86°F (15°-30°C) and protected from tampering.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.